All Type of News
54 products acquiring exclusive sales product approvals after Patent Linkage System enforcement
For a half year of the Patent Linkage System enforcement, 54 pharmaceutical products have acquired exclusive sales product approvals.
The Ministry of Food and Drug Safety(Minister Seung-hee Kimg, MFDS) announced 54 p...
CSO business rises again in the pharmaceutical field
CSOs(Contracts Sales Organization) have risen again.
Either mid-sized pharmaceutical companies, relatively less weaken in business marketing and product power, have actively used CSOs or each of their medical represe...
Pharmaceutical companies concealing the gift giving culture on holiday
“In principle, gifts are prohibited under the CP. I feel unsafe even as using my own money.” It is a complaint of a medical representative of a domestic mid-sized pharmaceutical company facing the Chuseok.
Thus, the ...
“Side effects of osteoporosis drugs have been exaggerated”
The Korean Society for Bone and Mineral Research(President Kyu-hyun Yang, orthopedist of Yonsei University College of Medicine)(KSBMR) announced the 2015 Position Statement of KSBMR focusing on the ‘importance of effe...
“Causing liver damage if using more than 400mg acetaminophen”
In the future, cold drugs and antipyretic analgesics containing acetaminophen must be marked with a statement(use precaution) to cause liver damage if exceeding the daily maximum volume, 400mg.
The Ministry of Food a...
Roche recalled Madopar Dispersible Tab due to wrong expiration datesAs expiration dates of ‘Madopar Dispersible Tab 125mg,’ a Roche’s Parkinson’s disease treatment, have been mistakenly marked, the company has recalled the product.
According to...
|
Listed pharmaceutical companies, “Weakening in both profitability and business activities”
It was indicated that while profitability of listed pharmaceutical companies have been weakened, efficiency of their business activities have also been dropped.
According to the YakupDotCom’s(www.yakup.com) analysis ...
Health insurance benefit details for antismoking treatments will be announced October
Delayed not to find the middle ground, the time to enforce the health insurance of antismoking treatments is going to be decided early-October.
The Ministry of Health and Welfare(MOHW) announced to disclose the time ...
BMS to file for an injunction of generic sales prohibition against Dong-A STIt was known that BMS has filed for an injunction to restrict sales against infringement of patent on Dong-A ST which has already launched a generic of ‘Baraclude,’ a mega-scale...
|
‘Soliris,’ a PNH treatment, applied by ‘Refund RSA’ next month
The only PNH(paroxysmal nocturnal hemoglobinuria) treatment, ‘Soliris,’ will be applied by RSA from October.
According to the industry concerned on the 18th, Soliris(eculizumab), which will face the ending of its ref...
